Active Shortage Injection Endocrinology/Metabolism
Dextrose Monohydrate 50% Inj · 1,698 days since initial FDA posting
Brand: DEXTROSE
FDA lists Dextrose Monohydrate 50% Inj as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Dextrose Monohydrate 50% Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dextrose Monohydrate 50% Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)
- Package NDC
- 0409-7517-16
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Jan 13, 2022
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Dextrose Shortage Records
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection